Which medication is known to potentially increase cholesterol levels in adolescents with hypertension?

Beta blockers are known to potentially increase cholesterol levels in adolescents with hypertension due to their pharmacological effects on lipid metabolism. Specifically, certain beta blockers can lead to an unfavorable lipid profile by raising levels of triglycerides and lowering levels of high-density lipoprotein (HDL) cholesterol. This is particularly significant in adolescents, who are already at risk for developing metabolic syndrome and cardiovascular complications.

While the other medication classes like calcium channel blockers, ACE inhibitors, and diuretics have their own side effects and considerations, they do not carry the same risk of adversely affecting lipid profiles as beta blockers do. Calcium channel blockers primarily affect vascular resistance and heart rate without significant impact on cholesterol levels. ACE inhibitors can have beneficial effects on lipid profiles and overall cardiovascular health, while diuretics primarily help with fluid regulation and lowering blood pressure, without a notable direct influence on cholesterol levels.